Nobiletin ameliorates diabetic nephropathy by modulating TP53-associated PANoptosis: an experimental study.

Zhang B, Liu Y, Ma L, Zhao Y, Dong Y, Zhou Z, Tian C, Wang D, Xu D, La X, Chang H, Han R, Li J, Wu C, Li J

DOI: 10.3389/fnut.2026.1816623
Published: 2026
Container: Frontiers in nutrition
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fnut.2026.1816623,
  title = {Nobiletin ameliorates diabetic nephropathy by modulating TP53-associated PANoptosis: an experimental study.},
  author = {Zhang B and Liu Y and Ma L and Zhao Y and Dong Y and Zhou Z and Tian C and Wang D and Xu D and La X and Chang H and Han R and Li J and Wu C and Li J},
  year = {2026},
  journal = {Frontiers in nutrition},
  doi = {10.3389/fnut.2026.1816623},
  url = {https://doi.org/10.3389/fnut.2026.1816623}
}

RIS

TY  - JOUR
TI  - Nobiletin ameliorates diabetic nephropathy by modulating TP53-associated PANoptosis: an experimental study.
AU  - Zhang B
AU  - Liu Y
AU  - Ma L
AU  - Zhao Y
AU  - Dong Y
AU  - Zhou Z
AU  - Tian C
AU  - Wang D
AU  - Xu D
AU  - La X
AU  - Chang H
AU  - Han R
AU  - Li J
AU  - Wu C
AU  - Li J
PY  - 2026
JO  - Frontiers in nutrition
DO  - 10.3389/fnut.2026.1816623
UR  - https://doi.org/10.3389/fnut.2026.1816623
ER  -

APA

B, Z., Y, L., L, M., Y, Z., Y, D., Z, Z., C, T., D, W., D, X., X, L., H, C., R, H., J, L., C, W., & J, L. (2026). Nobiletin ameliorates diabetic nephropathy by modulating TP53-associated PANoptosis: an experimental study.. Frontiers in nutrition. https://doi.org/10.3389/fnut.2026.1816623

Source records

pubmed · retrieved 2026-09-25T08:27:40.375Z